By Sally Robertson, B.Sc. Jun 10 2021 Researchers in the UK and Austria have identified a novel class of antibodies that is highly effective at neutralizing the original strain of severe acute respiratory syndrome (SARS-CoV-2) and maintaining blocking activity against certain viral variants that have emerged. The SARS-CoV-2 virus is the agent responsible for the ongoing...
